Pharma Focus America

Scorpius Holdings Reveals Expansion in San Antonio with New Cutting-Edge Storage and Testing Facility

Monday, May 20, 2024

Scorpius Holdings, Inc. (NYSE American: SCPX) has announced a significant expansion of its operational presence in San Antonio, Texas, with the unveiling of a new storage and testing facility. This expansion increases Scorpius' warehouse capacity from approximately 3,000 square feet to about 22,000 square feet, driven by the growing demand for its biomanufacturing services and the need to accommodate its expanding client base.

The newly established facility is designed to meet or exceed industry standards for the storage, continuity, and security of biopharmaceutical materials. It includes specialized storage areas maintained at temperatures between -20°C and -80°C for raw materials, as well as spaces for contained sampling and quality control testing. Additionally, it will provide storage for bulk drug substances to ensure clients' products are stored under optimal conditions throughout their development and production cycles.

A notable feature of the facility is its robust stability program, which enhances Scorpius' service offerings by providing in-house stability storage capabilities. This initiative not only expands the company's capabilities but also introduces an additional revenue stream, further strengthening Scorpius' position in the market.

Jeff Wolf, CEO of Scorpius Holdings, commented, "These new capabilities enable us to offer our clients continuity through their supply chain and meet their needs from process development through drug substance release. This strategic expansion reflects our commitment to excellence and our dedication to supporting our clients’ overall needs."



Thermo Fisher Scientific - mRNA ServicesFuture Labs Live USA 2024World Vaccine Congress Europe 2024World Orphan Drug Congress 2024Advanced Therapies USA 2024World Orphan Drug Congress Europe 2024